Leading Markets via Expanding Product Portfolios

• 1. Strengthening line-up of filler and medicine using Hyaluronic acid (HA) as Humedix’s own API
• 2. Expanding line-up of PDRN Pharmaceuticals and medical devices
• 3. Developing Platform technology manufacturing enzymatic deacetylated HA as a new material
• 4. Constructing HA raw material producing system (manufacturing plant construction)
•     → securing fermentation technology until 2020